Clinical TrialsSearch results
Number of results: 553
Other
- Japanese Diastolic Heart Failure Study
- Diastolic heart failure
- J-DHF Study group
- 2006-02-01
Other
- The Japan Home vs. Office blood pressure Measurement Evaluation with AI <J-HOME AI> Multi-center randomized controlled study on efficacy of PREMINENT (losartan 50 mg/HCTZ 12.5 mg) and high-dose Angiotensin Receptor Blockers (ARBs) on home blood pressure / clinic blood pressure / augmentation index / central blood pressure in patients with uncontrolled hypertension under moderate-dose ARB monotherapy
- Hypertension
- J-HOME AI Study group
- 2008-01-04
Other
- Randomiszd phase III trial of adjuvant chemotherapy with gemcitabine vs. S-1 in patients with resected pancreatic cancer
- Resected pancreatic cancer
- Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)
- 2007-04-01
Other
- Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Investigational study for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Other
- Multicenter study of a randomized controlled trial with or without maintenance/intensification therapy in patients with previously untreated acute promyelocytic leukemia (JALSG APL97 study)
- acute promyelocytic leukemia (APL)
- Japan Adult Leukemia Study Group
- 2005-09-14
Other
- Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with BCR-ABL-Negative Acute Lymphoblastic Leukemia (JALSG ALL202-U)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and idarubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia.
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2008-05-10